CoChat

Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen

Fokkens, W. J., Jogi, R., Reinartz, S., Sidorenko, I., Sitkauskiene, B., Van Oene, C., Faris, M. A., Ellsworth, A., Caldwell, M. F. · 2007 · Allergy
Cited by 103

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background: Fluticasone furoate is a new enhanced‐affinity glucocorticoid with a unique combination of pharmacodynamic and physicochemical properties suitable for topical activity. Methods: In this multicentre, randomized, double‐blind, placebo‐controlled, parallel‐group study, patients [adults and adolescents ≥12 years of age with seasonal allergic rhinitis (SAR)] received once‐daily (od) treatment for 2 weeks with either fluticasone furoate nasal spray 110 μg (n = 141) or placebo nasal spray (n = 144) administered in a unique, side‐actuated device. Efficacy measures included total nasal symptom score (TNSS) and total ocular symptom score (TOSS). Patients also reported their overall response to therapy and rated their quality of life using the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ). Results: Fluticasone furoate significantly improved the mean change from baseline in daily reflective TNSS compared with placebo (treatment difference of −1.757; P < 0.001). Fluticasone furoate was also significantly more effective in improving the morning predose instantaneous TNSS (treatment difference of −1.898; P < 0.001) and daily reflective TOSS (treatment difference of −0.741; P = 0.001). A significant treatment effect was observed as early as day 1. Compared with placebo‐treated patients, fluticasone furoate‐treated patients showed significantly greater improvements in overall evaluation of response to therapy (P < 0.001), as well as in overall RQLQ score (P < 0.001). Fluticasone furoate was well tolerated. Conclusion: Fluticasone furoate nasal spray 110 μg od was effective in improving the nasal symptoms of SAR. It also produced significant improvements in ocular symptoms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1398-9995.2007.01522.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 103

Metadata

Authors
Fokkens, W. J., Jogi, R., Reinartz, S., Sidorenko, I., Sitkauskiene, B., Van Oene, C., Faris, M. A., Ellsworth, A., & Caldwell, M. F.
Venue
Allergy
Publisher
Wiley
Published
2007-08-04
Volume
62
Issue
9
Pages
1078-1084
ISSN
  • 0105-4538 (ISSN-L)
  • 1398-9995
OpenAlex
W2031208354
Cited by
103
References
5
FWCI
8.85
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.